Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
2.250
-0.110 (-4.66%)
At close: Oct 8, 2025, 4:00 PM EDT
2.200
-0.050 (-2.22%)
After-hours: Oct 8, 2025, 5:46 PM EDT
Adagio Medical Holdings Employees
Adagio Medical Holdings had 80 employees as of December 31, 2024. The number of employees decreased by 5 or -5.88% compared to the previous year.
Employees
80
Change (1Y)
-5
Growth (1Y)
-5.88%
Revenue / Employee
$4,025
Profits / Employee
-$920,725
Market Cap
34.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80 | -5 | -5.88% |
| Dec 31, 2023 | 85 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADGM News
- 7 days ago - Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia - Business Wire
- 20 days ago - Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium - Business Wire
- 4 weeks ago - Adagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer Responsibilities - Business Wire
- 2 months ago - Adagio Medical Reports Second Quarter 2025 Results - Business Wire
- 5 months ago - Adagio Medical Reports First Quarter 2025 Results - Business Wire
- 5 months ago - Adagio Medical to Present at the BofA Securities 2025 Health Care Conference - Business Wire
- 6 months ago - Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System - Business Wire
- 6 months ago - Adagio Medical Appoints Deborah Kaster as Chief Business Officer - Business Wire